MS II Daclizumab

‹ Return to

Daclizumab: A humanised therapeutic antibody against the IL-2 receptor

Print Friendly, PDF & Email

Print Friendly, PDF & Email

Leave a Reply

Optional: Social Subscribe/Login

This site uses Akismet to reduce spam. Learn how your comment data is processed.